|
FY2022
12 months to Dec 25, 2022
|
FY2021
12 months to Dec 26, 2021
|
FY2020
12 months to Dec 27, 2020
|
FY2019
12 months to Dec 29, 2019
|
FY2018
12 months to Dec 30, 2018
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Deferred income taxes | |||||
| Non-cash interest expense | |||||
| Loss on impairment | |||||
| Stock-based compensation expense | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other | |||||
| Other assets | |||||
| Accounts payable and accrued expenses | |||||
| Deferred revenue | |||||
| Operating lease liabilities and assets | |||||
| Other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Acquisition of property and equipment | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Principal borrowings on long-term debt | |||||
| Principal repayments on long-term debt | |||||
| Principal borrowings from the CARES Act loan | |||||
| Principal repayments on the CARES Act loan | |||||
| Repurchase of common stock | |||||
| Net proceeds from the sale of common stock | |||||
| Cash dividend payments | |||||
| Tax payments from the vesting of restricted stock | |||||
| Deferred financing costs | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental disclosures of cash flow information: | |||||
| Interest, net of capitalized interest | |||||
| Income taxes | |||||
| Noncash investing and financing activities: | |||||
| Accrued acquisition of property and equipment | |||||
Loading...